Recently, some studies showed that there was an important link between albumin and the mitogen-activated protein kinase (MAPK) extracellular signal-regulated kinase, ERK1/ERK2 in kidney disease, and ERK1/2 signaling pathway was the downstream signal activated by albumin therapy [24, 51]. The gene discussed is MAPK3; the disease is kidney disorder.